This inventor holds 1 USPTO granted patent. Top assignee: Fresenius Kabi Oncology Limited. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Sachin Nain: Innovator in Pharmaceutical Chemistry
Introduction
Sachin Nain is a notable inventor based in Gurugram, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of important compounds. His work is characterized by a focus on improving processes that enhance the efficiency and effectiveness of drug development.
Latest Patents
Sachin Nain holds a patent for a process related to the preparation of Semaglutide side chain. The patent, which is classified under the title "Process for the preparation of Semaglutide side chain," outlines an improved method for synthesizing a compound of Formula (1). This compound is crucial in the synthesis of Semaglutide, a medication used for managing diabetes. His innovative approach also includes improved processes for preparing intermediates used in the synthesis of this compound. He has 1 patent to his name.
Career Highlights
Sachin Nain is currently employed at Fresenius Kabi Oncology Limited, where he applies his expertise in pharmaceutical development. His role involves working on advanced formulations and processes that contribute to the company's mission of providing high-quality oncology products. His dedication to innovation in this field has positioned him as a valuable asset to his team.
Collaborations
Sachin collaborates with talented professionals in his field, including coworkers Sridhar Male and Saswata Lahiri. Together, they work on various projects that aim to push the boundaries of pharmaceutical research and development.
Conclusion
Sachin Nain's contributions to pharmaceutical chemistry, particularly through his patent on Semaglutide synthesis, highlight his innovative spirit and commitment to advancing medical science. His work continues to impact the field positively, making him a noteworthy figure in the industry.